On one hand, AMPK activation suppresses aerobic glycolysis and tumor growth by inhibiting the mTOR/GSK3β axis, leading to downregulation of key glycolytic regulators including GLUT1, HK2, PFKFB3, and PKM2.65 The gene discussed is SLC2A1; the disease is neoplasm.